These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 29764060)

  • 1. The pharmacogenomics of warfarin from the COAG and EU-PACT: where do we go from here?
    Wu AH; Superko HR
    Per Med; 2014 May; 11(3):247-249. PubMed ID: 29764060
    [No Abstract]   [Full Text] [Related]  

  • 2. Monkey liver cytochrome P450 2C19 is involved in R- and S-warfarin 7-hydroxylation.
    Hosoi Y; Uno Y; Murayama N; Fujino H; Shukuya M; Iwasaki K; Shimizu M; Utoh M; Yamazaki H
    Biochem Pharmacol; 2012 Dec; 84(12):1691-5. PubMed ID: 23041648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-warfarin clearances from plasma associated with polymorphic cytochrome P450 2C19 and simulated by individual physiologically based pharmacokinetic models for 11 cynomolgus monkeys.
    Utoh M; Kusama T; Miura T; Mitsui M; Kawano M; Hirano T; Shimizu M; Uno Y; Yamazaki H
    Xenobiotica; 2018 Feb; 48(2):206-210. PubMed ID: 28136132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
    Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2015 Oct; 43(10):1408-16. PubMed ID: 26228688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomic Testing and Warfarin Management.
    Maluso A
    Oncol Nurs Forum; 2015 Sep; 42(5):563-5. PubMed ID: 26302287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of genetic and nongenetic factors in warfarin dosing algorithms.
    Wu AH
    Pharmacogenomics; 2007 Jul; 8(7):851-61. PubMed ID: 18240910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow R-warfarin 7-hydroxylation mediated by P450 2C19 genetic variants in cynomolgus monkeys in vivo.
    Utoh M; Yoshikawa T; Hayashi Y; Shimizu M; Iwasaki K; Uno Y; Yamazaki H
    Biochem Pharmacol; 2015 May; 95(2):110-4. PubMed ID: 25801008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin therapy--why one dose does not fit all!
    Kulkarni V; Bhave A; Munshi RK; Bhalerao S; Bhattad D; Khude S; Upase D
    J Assoc Physicians India; 2013 Aug; 61(8):571-3. PubMed ID: 24818346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acid substitutions that confer a high affinity for sulfaphenazole binding and a high catalytic efficiency for warfarin metabolism to P450 2C19.
    Jung F; Griffin KJ; Song W; Richardson TH; Yang M; Johnson EF
    Biochemistry; 1998 Nov; 37(46):16270-9. PubMed ID: 9819219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trial.
    Ragia G; Kolovou V; Kolovou G; Konstantinides S; Maltezos E; Tavridou A; Tziakas D; Maitland-van der Zee AH; Manolopoulos VG
    Pharmacogenomics; 2017 Jan; 18(1):23-34. PubMed ID: 27967328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacogenomics of warfarin and clopidogrel.
    Shin J
    J Pharm Pract; 2012 Aug; 25(4):428-38. PubMed ID: 22674970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
    Chainuvati S; Nafziger AN; Leeder JS; Gaedigk A; Kearns GL; Sellers E; Zhang Y; Kashuba AD; Rowland E; Bertino JS
    Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen.
    Wigle TJ; Jansen LE; Teft WA; Kim RB
    J Pers Med; 2017 Dec; 7(4):. PubMed ID: 29236081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possible application of pharmacogenomics to warfarin therapy].
    Murata M
    Rinsho Byori; 2011 Jun; 59(6):594-7. PubMed ID: 21815482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design.
    van Schie RM; Wadelius MI; Kamali F; Daly AK; Manolopoulos VG; de Boer A; Barallon R; Verhoef TI; Kirchheiner J; Haschke-Becher E; Briz M; Rosendaal FR; Redekop WK; Pirmohamed M; Maitland van der Zee AH
    Pharmacogenomics; 2009 Oct; 10(10):1687-95. PubMed ID: 19842940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the acenocoumarol EU-PACT algorithms: similar performance in the Rotterdam Study cohort as in the original study.
    van Schie RM; el Khedr N; Verhoef TI; Teichert M; Stricker BH; Hofman A; Buhre PN; Wessels JA; Schalekamp T; le Cessie S; van der Meer FJ; Rosendaal FR; de Boer A; Maitland-van der Zee AH; Visser LE
    Pharmacogenomics; 2012 Aug; 13(11):1239-45. PubMed ID: 22920394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin pharmacogenomics.
    Cavallari LH; Limdi NA
    Curr Opin Mol Ther; 2009 Jun; 11(3):243-51. PubMed ID: 19479657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.
    Carlquist JF; Horne BD; Muhlestein JB; Lappé DL; Whiting BM; Kolek MJ; Clarke JL; James BC; Anderson JL
    J Thromb Thrombolysis; 2006 Dec; 22(3):191-7. PubMed ID: 17111199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.